Best Follicular Lymphoma Hospital in India
A diagnosis of Follicular Lymphoma can be overwhelming, but with advances in modern hematology, patients today have access to highly effective treatments that offer long-term disease control and an excellent quality of life. Choosing the Best Follicular Lymphoma Hospital in India is one of the most important decisions because successful Follicular Lymphoma treatment in India depends on early diagnosis, accurate staging, experienced hematologists, advanced molecular diagnostics, personalized treatment planning, and access to the latest immunotherapy, targeted therapy, CAR-T Cell Therapy, and Bone Marrow Transplant when required.
At BMT Next, we are committed to delivering world-class Follicular Lymphoma treatment in India through a dedicated multidisciplinary team of hematologists, hemato-oncologists, Bone Marrow Transplant specialists, molecular pathologists, radiation oncologists, and supportive care experts. Led by Dr. Meet Kumar, our team has 20+ years of hematology expertise and has successfully performed 1400+ Bone Marrow Transplants. Patients from 20+ countries trust us for comprehensive blood cancer treatment in India, advanced diagnostics, precision medicine, and internationally accepted treatment protocols. We also provide funding assistance programs for eligible patients, ensuring that more patients can access high-quality Follicular Lymphoma treatment in India.
Whether you are looking for the Best Follicular Lymphoma Hospital in India, Follicular Lymphoma treatment in Gurugram, Follicular Lymphoma treatment in Faridabad, or seeking a second opinion from an experienced Follicular Lymphoma specialist, BMT Next offers complete care under one roof. Patients from Delhi NCR, Haryana, Rajasthan, Uttar Pradesh, and across India choose our centers for Follicular Lymphoma treatment in Gurugram and Follicular Lymphoma treatment in Faridabad because of our expertise in managing both newly diagnosed and relapsed lymphoma. From diagnosis and staging to immunotherapy, chemotherapy, targeted therapy, CAR-T Cell Therapy, Bone Marrow Transplant, and survivorship care, every treatment plan is personalized to maximize outcomes.
What is Follicular Lymphoma?
Follicular Lymphoma is the second most common type of Non-Hodgkin Lymphoma and one of the most common indolent (slow-growing) B-cell lymphomas. Follicular Lymphoma develops from germinal center B lymphocytes inside the lymph nodes, where acquired genetic changes allow these abnormal cells to survive and multiply uncontrollably. Although Follicular Lymphoma usually grows more slowly than aggressive lymphomas, it should never be ignored because the disease can gradually spread to multiple lymph node regions, the bone marrow, spleen, liver, or other organs. Early consultation at the Best Follicular Lymphoma Hospital in India helps ensure accurate diagnosis and timely Follicular Lymphoma treatment in India.
Many patients with Follicular Lymphoma first notice painless swollen lymph nodes in the neck, underarms, or groin. Others may remain symptom-free for months or even years, with the disease discovered incidentally during imaging or routine blood investigations. Because Follicular Lymphoma often behaves differently from aggressive lymphomas, every patient requires an individualized treatment strategy rather than immediate chemotherapy. Patients seeking Follicular Lymphoma treatment in Gurugram or Follicular Lymphoma treatment in Faridabad benefit from evaluation by experienced hematologists who can determine whether active surveillance or immediate treatment is the most appropriate approach.
Modern Follicular Lymphoma treatment in India has evolved remarkably over the last decade. Depending on disease stage, tumor burden, symptoms, and overall health, treatment may include active surveillance (watch-and-wait), Rituximab, Obinutuzumab, Bendamustine-Rituximab (BR), R-CHOP, R-CVP, targeted therapy, radiation therapy, CAR-T Cell Therapy, or Autologous Stem Cell Transplant for selected patients. At the Best Follicular Lymphoma Hospital in India, treatment is individualized according to the biology of the disease, ensuring patients receive the most effective therapy while minimizing unnecessary treatment-related side effects.
A hallmark feature of Follicular Lymphoma is the t(14;18) chromosomal translocation, which causes overexpression of the BCL2 gene and prevents lymphoma cells from undergoing normal programmed cell death. In a small proportion of patients, Follicular Lymphoma can undergo histologic transformation into Diffuse Large B-Cell Lymphoma (DLBCL), an aggressive lymphoma requiring urgent treatment. This is one reason why long-term follow-up at the Best Follicular Lymphoma Hospital in India is essential, even for patients whose disease is initially slow growing.
At BMT Next, patients undergoing Follicular Lymphoma treatment in India, Follicular Lymphoma treatment in Gurugram, or Follicular Lymphoma treatment in Faridabad receive comprehensive evaluation using lymph node biopsy, Immunohistochemistry (IHC), Flow Cytometry, PET-CT, Bone Marrow Biopsy, FISH testing, and advanced molecular diagnostics. We also calculate the Follicular Lymphoma International Prognostic Index (FLIPI) and FLIPI-2 to accurately estimate prognosis and personalize Follicular Lymphoma treatment in India according to the latest NCCN, ESMO, and WHO Classification guidelines.
Symptoms of Follicular Lymphoma
The symptoms of Follicular Lymphoma often develop gradually because it is an indolent (slow-growing) Non-Hodgkin Lymphoma. Many patients remain symptom-free for months or even years, while others experience slowly enlarging lymph nodes or generalized symptoms that progress over time. Because early Follicular Lymphoma may not cause significant discomfort, patients often delay seeking medical attention. However, early consultation with a hematologist at the Best Follicular Lymphoma Hospital in India can help establish an accurate diagnosis and determine whether immediate Follicular Lymphoma treatment in India or careful monitoring is the most appropriate approach.
The most common sign of Follicular Lymphoma is a painless enlarged lymph node in the neck, armpit, or groin. As Follicular Lymphoma progresses, it may involve multiple lymph node regions, the bone marrow, spleen, liver, or other organs, leading to additional symptoms. Patients seeking Follicular Lymphoma treatment in Gurugram or Follicular Lymphoma treatment in Faridabad should never ignore persistent swollen lymph nodes lasting more than two to four weeks.
Common Symptoms of Follicular Lymphoma
Patients with Follicular Lymphoma may experience:
- Painless enlarged lymph nodes
- Swelling in the neck, armpit, or groin
- Persistent fatigue
- Fever without infection
- Drenching night sweats
- Unexplained weight loss
- Loss of appetite
- Persistent weakness
- Abdominal fullness due to enlarged spleen
- Abdominal swelling
- Recurrent infections
- Breathlessness if chest lymph nodes are enlarged
Doctors refer to fever, drenching night sweats, and unexplained weight loss as B symptoms, which are important for staging Follicular Lymphoma and planning Follicular Lymphoma treatment in India. Some patients with Follicular Lymphoma may also develop anemia, low blood counts, or recurrent infections when the bone marrow becomes involved.
Although Follicular Lymphoma usually grows slowly, patients should remember that the disease can occasionally undergo histologic transformation into Diffuse Large B-Cell Lymphoma (DLBCL), an aggressive lymphoma requiring urgent treatment. New rapidly enlarging lymph nodes, severe pain, rapidly worsening symptoms, or high fever should prompt immediate evaluation at the Best Follicular Lymphoma Hospital in India.
Risk Factors for Follicular Lymphoma
The exact cause of Follicular Lymphoma remains unknown, but several factors have been associated with an increased risk of developing this B-cell Non-Hodgkin Lymphoma.
Risk factors include:
- Increasing age
- Family history of lymphoma (uncommon)
- Immune system dysfunction
- Autoimmune disorders
- Chronic immune stimulation
- Environmental and occupational chemical exposure
- Previous radiation exposure
- Rare inherited genetic susceptibility
It is important to understand that many patients diagnosed with Follicular Lymphoma have no identifiable risk factors. Therefore, persistent swollen lymph nodes or unexplained symptoms should always be evaluated by an experienced Follicular Lymphoma specialist, regardless of family history.
When Should You Consult a Hematologist?
Patients should consult a hematologist or Follicular Lymphoma specialist if they experience:
- Enlarged lymph nodes persisting for more than two weeks
- Multiple swollen lymph nodes
- Fever without infection
- Night sweats
- Unexplained weight loss
- Persistent fatigue
- Recurrent infections
- Enlarged spleen
- Abnormal CBC
- Persistent abdominal swelling
If you are searching for Follicular Lymphoma treatment in India, Follicular Lymphoma treatment in Gurugram, Follicular Lymphoma treatment in Faridabad, or the Best Follicular Lymphoma Hospital in India, early consultation with an experienced hematology team can help establish the diagnosis before the disease progresses.
Diagnosis of Follicular Lymphoma
Accurate diagnosis is essential before starting Follicular Lymphoma treatment. At BMT Next, every patient undergoes a comprehensive evaluation using advanced pathology, molecular diagnostics, and imaging to confirm the diagnosis, determine the stage, calculate the FLIPI score, and develop a personalized Follicular Lymphoma treatment in India.
Lymph Node Biopsy
An excisional lymph node biopsy is the gold standard for diagnosing Follicular Lymphoma. It provides adequate tissue for detailed pathological examination and grading.
Immunohistochemistry (IHC)
Immunohistochemistry (IHC) confirms Follicular Lymphoma using markers including CD20, CD10, BCL2, BCL6, CD79a, and Ki-67, helping differentiate it from other lymphomas.
Flow Cytometry
Flow Cytometry identifies abnormal B-cell populations and supports the diagnosis of Follicular Lymphoma while excluding other hematological malignancies.
PET-CT Scan
A PET-CT scan helps determine the extent of Follicular Lymphoma, identifies active disease sites, evaluates suspected histologic transformation, and monitors treatment response after therapy.
Bone Marrow Biopsy
A Bone Marrow Biopsy determines whether Follicular Lymphoma has spread to the bone marrow, which is common in advanced-stage disease and influences staging and treatment decisions.
FISH & Molecular Testing
FISH testing identifies the characteristic t(14;18) translocation and evaluates additional molecular abnormalities. These findings assist in confirming Follicular Lymphoma, assessing prognosis, and selecting the most appropriate Follicular Lymphoma treatment in India.
Staging & FLIPI Prognostic Score
After confirming the diagnosis, Follicular Lymphoma is staged using the Lugano Classification (Ann Arbor staging system).
- Stage I: One lymph node region or one extranodal site.
- Stage II: Two or more lymph node regions on the same side of the diaphragm.
- Stage III: Lymph node involvement on both sides of the diaphragm.
- Stage IV: Spread to the bone marrow or other organs.
In addition to disease stage, our specialists calculate the Follicular Lymphoma International Prognostic Index (FLIPI) and FLIPI-2, which evaluate age, hemoglobin level, LDH, number of lymph node areas involved, stage, and bone marrow involvement. These internationally accepted prognostic models help personalize Follicular Lymphoma treatment in India, estimate long-term outcomes, and guide decisions regarding observation, immunotherapy, chemotherapy, targeted therapy, or transplant.
Why BMT Next for Follicular Lymphoma Treatment?
Choosing the Best Follicular Lymphoma Hospital in India is one of the most important decisions after a diagnosis because the quality of diagnosis, staging, treatment planning, and long-term follow-up directly influences outcomes. At BMT Next, we combine 20+ years of hematology expertise with advanced technology, internationally accepted treatment protocols, and personalized care to provide comprehensive Follicular Lymphoma treatment in India. Whether you are seeking Follicular Lymphoma treatment in Gurugram, Follicular Lymphoma treatment in Faridabad, or a second opinion from experienced lymphoma specialists, our multidisciplinary team delivers evidence-based care tailored to each patient’s disease biology and treatment goals.
Our expert team, led by Dr. Meet Kumar, along with Dr. Neeraj Teotia, Dr. Paras Satadeve, and Dr. Umesh Yadav, specializes in treating Follicular Lymphoma, Non-Hodgkin Lymphoma, leukemia, multiple myeloma, and other complex blood disorders. Every patient undergoes comprehensive evaluation using advanced PET-CT, Flow Cytometry, Immunohistochemistry (IHC), Bone Marrow Biopsy, FISH testing, and molecular diagnostics to accurately diagnose Follicular Lymphoma, calculate the FLIPI score, identify high-risk features, and create a personalized Follicular Lymphoma treatment plan according to the latest NCCN, ESMO, and WHO guidelines.
At BMT Next, we understand that Follicular Lymphoma behaves differently in every patient. Some patients benefit from active surveillance (watch-and-wait), while others require immunotherapy, chemotherapy, targeted therapy, radiation therapy, CAR-T Cell Therapy, or Autologous Stem Cell Transplant. Our multidisciplinary lymphoma tumor board carefully evaluates every case to ensure that each patient receives the most appropriate Follicular Lymphoma treatment in India, avoiding both under-treatment and unnecessary therapy.
With 1400+ successful Bone Marrow Transplants, patients from 20+ countries, internationally trained hematologists, advanced transplant facilities, dedicated infection control, modern day-care chemotherapy services, and funding assistance programs for eligible patients, BMT Next has earned the trust of patients seeking the Best Follicular Lymphoma Hospital in India. From your first consultation to diagnosis, treatment, survivorship, and long-term follow-up, our mission is to deliver compassionate, evidence-based Follicular Lymphoma treatment in India while helping patients achieve the best possible clinical outcomes and quality of life.
